UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  February 6, 2018

 

Axcelis Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-30941

 

34-1818596

(State or other jurisdiction

 

(Commission

 

(IRS Employer

of incorporation)

 

File Number)

 

Identification No.)

 

108 Cherry Hill Drive, Beverly, Massachusetts

 

01915

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:  (978) 787-4000

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2). Emerging growth company o

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

 

 



 

Item 2.02 Results of Operations and Financial Condition

 

On February 6, 2018, Axcelis Technologies, Inc. (the “Company”) issued a press release regarding its financial results for the fourth quarter and full year ended December 31, 2017.  The Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

 

Item 9.01   Financial Statements and Exhibits.

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press Release dated February 6, 2018. Filed herewith.

 

2



SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 6, 2018

Axcelis Technologies, Inc.

 

 

 

By:

/s/ KEVIN J. BREWER

 

 

Kevin J. Brewer

 

 

Executive Vice President

 

 

and Chief Financial Officer

 

3


Exhibit 99.1

 

 

News Release

 

AXCELIS ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2017

 

Annual Systems Revenues Increased by 89%; Reversed Deferred Tax Valuation Allowance

 

BEVERLY, Mass. — February 6, 2018—Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2017.

 

The Company reported fourth quarter revenue of $116.4 million, compared to $104.5 million for the third quarter of 2017. Operating profit for the quarter was $10.8 million, compared to $13.8 million for the third quarter. Net income for the quarter was $91.7 million, or $2.68 per diluted share, compared to net income for the third quarter of 2017 of $11.8 million, or $0.35 per diluted share. Cash, cash equivalents and restricted cash were $140.9 million at December 31, 2017, compared to $120.7 million on September 30, 2017. In the fourth quarter, the Company recorded an excess inventory reserve of $6.2 million associated with its Legacy business, and reversed the valuation allowance on its deferred tax assets, which, together with related impacts, resulted in a benefit provisionally determined to be $81.6 million. Adjusting for these events, on a non-GAAP basis, quarter over quarter, the Company grew operating profit to $16.9 million, an increase of 22% over the third quarter, and increased diluted earnings per share to $0.47, an increase of 24% over the non-GAAP diluted earnings per share in the third quarter.

 

For the full year 2017, the Company reported revenue of $410.6 million, compared with $267.0 million for the full year 2016. Systems revenue for the year was $262.7 million, compared to $139.3 million in 2016. Operating profit was $47.8 million in 2017, compared to $16.6 million in 2016. Net income for the year was $127.0 million, compared to net income of $11.0 million in 2016. Diluted earnings per share for the full year was $3.80, in comparison to $0.36 in 2016. Adjusting for the two fourth quarter accounting events discussed above, on a non-GAAP basis, year over year, the Company’s operating profit was $54.0 million, an increase of 225% over 2016, and increased diluted earnings per share to $1.48, an increase of 311% over 2016.

 

“We are very pleased with our 2017 results and expect continued market strength and growth in 2018,” said President and CEO Mary Puma. “Regaining market share leadership in ion implantation remains our primary objective. With Purion now a tool of record at 7 of the top 10 semiconductor CAPEX spenders, we have confidence we can achieve this.”

 

Chief Financial Officer and Executive Vice President Kevin Brewer commented, “We are pleased to announce the reversal of our valuation allowance on our deferred tax assets as a direct result of our thirteen consecutive

 



 

quarters of profitability, combined with our positive outlook for 2018 and beyond.”

 

Q4 2017 Financial Highlights:

 

 

 

GAAP

 

Non-GAAP

 

 

 

 

 

 

 

 

 

 

 

Period-to-Period
Change

 

 

 

Q4 2017

 

Q3 2017

 

Q4 2017 (1)

 

Q3 2017 (2)

 

$

 

%

 

Total revenue ($M)

 

$

116.4

 

$

104.5

 

$

116.4

 

$

104.5

 

$

11.9

 

11.4

%

Gross profit ($M)

 

$

36.7

 

$

39.8

 

$

42.9

 

$

39.8

 

$

3.1

 

7.8

%

Gross profit (% of total revenue)

 

31.5

%

38.0

%

36.8

%

38.0

%

 

 

 

 

Income from operations ($M)

 

$

10.8

 

$

13.8

 

$

16.9

 

$

13.8

 

$

3.1

 

22.5

%

Net income ($M)

 

$

91.7

 

$

11.8

 

$

16.2

 

$

12.7

 

$

3.5

 

27.6

%

Net income per share (diluted)

 

$

2.68

 

$

0.35

 

$

0.47

 

$

0.38

 

$

0.09

 

23.7

%

 

Full Year 2017 Financial Highlights:

 

 

 

GAAP

 

Non-GAAP

 

 

 

 

 

 

 

 

 

 

 

Period-to-Period
Change

 

 

 

2017

 

2016

 

2017 (1)

 

2016

 

$

 

%

 

Total revenue ($M)

 

$

410.6

 

$

267.0

 

$

410.6

 

$

267.0

 

$

143.6

 

53.8

%

Gross profit ($M)

 

$

150.2

 

$

99.6

 

$

156.4

 

$

99.6

 

$

56.8

 

57.0

%

Gross profit (% of total revenue)

 

36.6

%

37.3

%

38.1

%

37.3

%

 

 

 

 

Income from operations ($M)

 

$

47.8

 

$

16.6

 

$

54.0

 

$

16.6

 

$

37.4

 

225.3

%

Net income ($M)

 

$

127.0

 

$

11.0

 

$

49.5

 

$

11.0

 

$

38.5

 

350.0

%

Net income per share (diluted)

 

$

3.80

 

$

0.36

 

$

1.48

 

$

0.36

 

$

1.12

 

311.1

%

 


(1) A reconciliation of the fourth quarter and full year ending December 31, 2017 GAAP and non-GAAP results is provided in the financial tables included in this release. See also “Use of Non-GAAP Adjusted Financial Measures” below.

 

(2) Non-GAAP Q3 2017 net income and diluted earnings per share eliminate the effects of Accounting Standards Update No. 2016-09, which decreased net income by $0.8 million and decreased diluted earnings per share by $0.03.

 

On December 22, 2017, the Tax Cuts and Jobs Act (“TCJA”) was enacted. The TCJA significantly revised the U.S. federal corporate income tax by, among other things, lowering the corporate income tax rate to 21%.  U.S. GAAP accounting for income taxes requires that Axcelis record the impacts of any tax law change in the quarter that the tax law change is enacted. Due to the complexities involved in accounting for the enactment of TCJA, as permitted by SEC Staff Accounting Bulletin (“SAB”) 118, we have determined a provisional estimate of the impacts of the TCJA in our financial statements for the fourth quarter and year ending December 31, 2017.  Accordingly, Axcelis’ estimate of the effects of the TCJA, based on currently available information, are presented above and reflected on the balance sheet and income statement for the fourth quarter and year ending December 31, 2017 included in this press release. Axcelis recorded a $1.0 million tax expense as a result of the TCJA, primarily from the net impact of the revaluation of our deferred tax assets utilizing the enacted tax rate at the time they are anticipated to be realized less the estimated United States toll charge associated with

 



 

undistributed accumulated foreign earnings. This reflects our current estimate of the U.S. income tax effects of the TCJA, however these are provisional amounts subject to adjustment during the one year measurement period. Taking into account the estimated impacts of the TCJA, we currently expect the 2018 effective tax rate to be approximately 22%. The impact of the TCJA may differ from these estimates, possibly materially, due to, among other things, changes in interpretations and assumptions we have made, federal tax regulations and guidance that may be issued by the U.S. Department of the Treasury and actions we may take as a result of the Tax Act. Axcelis will continue to analyze the effects of the TCJA on its financial statements and operations. Adjustments to these provisional estimates and additional impacts, if any, from the enactment of the TCJA will be recorded as they are identified during the measurement period as provided for in SAB 118.

 

Use of Non-GAAP Adjusted Financial Measures
In this press release, Axcelis provides investors with certain non-GAAP adjusted financial measures, which are adjusted to exclude the impact of two events in the fourth quarter of 2017 discussed above: a significant excess inventory reserve adjustment associated with our Legacy business; and the reversal of the valuation allowance on the Company’s deferred tax assets. Reconciliations of these non-GAAP measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are provided in the financial tables included in this release. In addition, Axcelis provides non-GAAP adjusted net income and earnings per diluted share for the third quarter of 2017, which exclude the impact of Accounting Standard Update 2016-09. This ASU addresses accounting for equity compensation expense and related tax effects.  These non-GAAP third quarter items are reconciled in the footnote to the Q4 2017 Financial Highlights table above.

 

Management uses these non-GAAP adjusted financial measures to evaluate the Company’s operating and financial performance and for planning purposes. Axcelis believes these measures enhance an overall understanding of our performance and investors’ ability to review the Company’s business from the same perspective as the Company’s management, and facilitate comparisons of this period’s results with prior periods on a consistent basis by excluding items that we do not believe are indicative of our ongoing operating performance. There are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with generally accepted accounting principles, may be different from non-GAAP financial measures used by other companies, and may exclude certain items that may have a material impact upon our reported financial results. The presentation of this additional information is not meant to be considered in isolation or as a substitute for the directly comparable financial measures prepared in accordance with GAAP.

 



 

Business Outlook

 

For the first quarter ending March 31, 2018, Axcelis expects revenues of between $115 and $120 million dollars. Gross margin in the first quarter is expected to be around 38%. First quarter operating profit is forecasted to be approximately $16-17 million. With the reversal of the valuation allowance on our deferred tax asset, Axcelis will become a taxpayer for accounting purposes in 2018. Therefore, earnings per share is expected to be between $0.34 and $0.37, which includes $0.10 of non-cash tax expense.

 

Fourth Quarter 2017 Conference Call

 

The Company will host a conference call today at 5:00 pm ET to discuss the Company’s results for the fourth quarter and full year. The call will be available to interested listeners via an audio webcast on the Investors page of Axcelis’ website at www.axcelis.com, or by dialing 866.588.8911 (707.294.1561 outside North America).  Participants calling into the conference call will be requested to provide the company name, Axcelis Technologies, and pass code: 5651308. Webcast replays will be available for 30 days following the call.

 

Safe Harbor Statement

 

This press release and the conference call contain forward-looking statements under the Private Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for spending in our industry and guidance for future financial performance, are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are outside the control of the Company, including that customer decisions to place orders or our product shipments may not occur when we expect, that orders may not be converted to revenue in any particular quarter, or at all, whether demand will continue for the semiconductor equipment we produce or, if not, whether we can successfully meet changing market requirements, and whether we will be able to maintain continuity of business relationships with and purchases by major customers. Increased competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and instability caused by changing global economic, political or financial conditions could also could cause actual results to differ materially from those in our forward-looking statements. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

 

About Axcelis:

 

Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 40 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one

 



 

of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

 

Company Contacts

 

Investor Relations:

Doug Lawson
978.787.9552

 

Editorial/Media:

Maureen Hart
978.787.4266

 



 

Axcelis Technologies, Inc.

Consolidated Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

 

 

 

Three months ended
December 31,

 

Twelve months ended
December 31,

 

 

 

2017

 

2016

 

2017

 

2016

 

 

 

 

 

 

 

 

 

 

 

Revenue:

 

 

 

 

 

 

 

 

 

Product

 

$

110,446

 

$

63,959

 

$

387,124

 

$

244,295

 

Services

 

5,950

 

5,399

 

23,437

 

22,685

 

Total revenue

 

116,396

 

69,358

 

410,561

 

266,980

 

Cost of Revenue:

 

 

 

 

 

 

 

 

 

Product

 

72,390

 

37,745

 

234,932

 

149,007

 

Services

 

7,286

 

4,666

 

25,382

 

18,375

 

Total cost of revenue

 

79,676

 

42,411

 

260,314

 

167,382

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

36,720

 

26,947

 

150,247

 

99,598

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

10,917

 

8,795

 

43,071

 

34,402

 

Sales and marketing

 

7,197

 

6,097

 

28,532

 

23,839

 

General and administrative

 

7,842

 

6,190

 

30,802

 

24,452

 

Restructuring charges

 

 

 

 

282

 

Total operating expenses

 

25,956

 

21,082

 

102,405

 

82,975

 

 

 

 

 

 

 

 

 

 

 

Income from operations

 

10,764

 

5,865

 

47,842

 

16,623

 

 

 

 

 

 

 

 

 

 

 

Other (expense) income:

 

 

 

 

 

 

 

 

 

Interest income

 

315

 

77

 

714

 

238

 

Interest expense

 

(1,337

)

(1,346

)

(5,121

)

(5,073

)

Other, net

 

396

 

(412

)

396

 

(764

)

Total other expense

 

(626

)

(1,681

)

(4,011

)

(5,599

)

 

 

 

 

 

 

 

 

 

 

Income before income taxes

 

10,138

 

4,184

 

43,831

 

11,024

 

 

 

 

 

 

 

 

 

 

 

Income tax (benefit) provision

 

(81,542

)

219

 

(83,128

)

23

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

91,680

 

$

3,965

 

$

126,959

 

$

11,001

 

 

 

 

 

 

 

 

 

 

 

Net income per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

2.88

 

$

0.13

 

$

4.11

 

$

0.38

 

Diluted

 

$

2.68

 

$

0.13

 

$

3.80

 

$

0.36

 

 

 

 

 

 

 

 

 

 

 

Shares used in computing net income per share:

 

 

 

 

 

 

 

 

 

Basic weighted average common shares

 

31,801

 

29,423

 

30,866

 

29,195

 

Diluted weighted average common shares

 

34,198

 

31,436

 

33,436

 

30,947

 

 



 

Axcelis Technologies, Inc.

Consolidated Balance Sheets

(In thousands, except per share amounts)

(Unaudited)

 

 

 

December 31,

 

December 31,

 

 

 

2017

 

2016

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

Cash and cash equivalents

 

$

133,407

 

$

70,791

 

Accounts receivable, net

 

75,302

 

50,573

 

Inventories, net

 

120,544

 

113,853

 

Prepaid expenses & other assets

 

32,176

 

28,327

 

Property, plant and equipment, net

 

36,168

 

30,840

 

Restricted cash

 

7,473

 

6,864

 

Deferred income taxes

 

83,148

 

983

 

Total assets

 

$

488,218

 

$

302,231

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Accounts payable

 

$

32,642

 

$

24,996

 

Accrued compensation

 

20,955

 

5,142

 

Warranty

 

4,502

 

2,668

 

Income taxes

 

273

 

240

 

Deferred revenue

 

18,145

 

11,009

 

Sale leaseback obligation

 

47,714

 

47,586

 

Other liabilities

 

10,377

 

9,135

 

Total liabilities

 

134,608

 

100,776

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Common stock, $0.001 par value, 75,000 shares authorized; 32,048 shares issued and outstanding at December 31, 2017; 29,518 shares issued and outstanding at December 31, 2016

 

32

 

30

 

Additional paid-in capital

 

556,147

 

535,408

 

Accumulated deficit

 

(204,745

)

(331,704

)

Accumulated other comprehensive income (loss)

 

2,176

 

(2,279

)

Total stockholders’ equity

 

353,610

 

201,455

 

Total liabilities and stockholders’ equity

 

$

488,218

 

$

302,231

 

 



 

Reconciliation of GAAP Cost of Revenue, Gross Profit, Income From Operations and Net Income to

Non-GAAP Cost of Revenue, Gross Profit, Income From Operations and Net Income

(In thousands, except per share amounts)

(unaudited)

 

 

 

Three months ended
December 31,

 

Twelve months ended
December 31,

 

 

 

2017

 

2016

 

2017

 

2016

 

Total cost of revenue:

 

 

 

 

 

 

 

 

 

GAAP total cost of revenue

 

$

79,676

 

$

42,411

 

$

260,314

 

$

167,382

 

Excess inventory reserve

 

(6,168

)

 

(6,168

)

 

Non-GAAP total cost of revenue

 

$

73,508

 

$

42,411

 

$

254,146

 

$

167,382

 

 

 

 

 

 

 

 

 

 

 

Gross profit:

 

 

 

 

 

 

 

 

 

GAAP gross profit

 

$

36,720

 

$

26,947

 

$

150,247

 

$

99,598

 

Excess inventory reserve

 

6,168

 

 

6,168

 

 

Non-GAAP gross profit

 

$

42,888

 

$

26,947

 

$

156,415

 

$

99,598

 

 

 

 

 

 

 

 

 

 

 

Income from operations:

 

 

 

 

 

 

 

 

 

GAAP income from operations

 

$

10,764

 

$

5,865

 

$

47,842

 

$

16,623

 

Excess inventory reserve

 

6,168

 

 

6,168

 

 

Non-GAAP income from operations

 

$

16,932

 

$

5,865

 

$

54,010

 

$

16,623

 

 

 

 

 

 

 

 

 

 

 

Net income:

 

 

 

 

 

 

 

 

 

GAAP net income

 

$

91,680

 

$

3,965

 

$

126,959

 

$

11,001

 

Excess inventory reserve

 

6,168

 

 

6,168

 

 

Tax valuation release

 

(81,641

) (1)

 

(83,642

) (2)

 

Non-GAAP net income

 

$

16,207

 

$

3,965

 

$

49,485

 

$

11,001

 

 

 

 

 

 

 

 

 

 

 

Net income per share (diluted):

 

 

 

 

 

 

 

 

 

GAAP net income per share

 

$

2.68

 

$

0.13

 

$

3.80

 

$

0.36

 

Excess inventory reserve

 

0.18

 

 

0.18

 

 

Tax valuation release

 

(2.39

) (1)

 

(2.50

) (2)

 

Non-GAAP net income per share

 

$

0.47

 

$

0.13

 

$

1.48

 

$

0.36

 

 


(1) Principally due to the release of our deferred tax assets valuation allowance and related impacts.

 

(2) Principally due to the release of our deferred tax assets valuation allowance and related impacts. Also includes prior quarter tax benefits associated with the effect of Accounting Standards Update No. 2016-09.